11:05 AM EDT, 05/11/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts opened the week on a flat note Monday morning, edging 0.08% higher to 1,835.34 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and biopharmaceutical company Cellectis ( CLLS ) , which advanced 8.1% and 6.3% respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and telecommunications company Ericsson (ERIC), which increased 4.9% and 3.2% respectively.

The decliners from continental Europe were led by consumer goods company Unilever ( UL ) and biopharmaceutical company Grifols ( GRFS ) , which fell 1.9% and 1.3% respectively. They were followed by internet browser company Opera (OPRA) and accommodations booking site trivago (TRVG), which were down 1% each.

The gainers from the UK were led by cruise line operator Carnival (CUK) and pharmaceutical company Silence Therapeutics ( SLN ) , which rose 6.6% and 4.7% respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Amarin ( AMRN ) , which were up 3.9% and 3.4% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Mereo BioPharma Group ( MREO ) , which lost 10% and 7.3% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and software firm Endava ( DAVA ) , which dropped 5.8% and 2.2% respectively.